TAFAZZIN and sarcoma: Proliferation and tumour progression in 50% of sarcoma cases are also associated with the aberrant constitutive activation of Yes1 associate protein (YAP) and Tafazzin (TAZ) transcription factors due to genomic alterations in the Hippo pathway [27].